Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1984-12-05
1986-04-15
Friedman, Stanley J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
424 10, 514812, A61V 3144
Patent
active
045828350
ABSTRACT:
A method of treating pain which comprises the administration to a patient of a parenterally or sublingually effective dose of buprenorphine together with an amount of naloxone sufficient to prevent substitution in an opiate dependent subject. Preferably when the administration is parenteral the weights of naloxone and buprenorphine are within the ratio of 1:3 to 1:1 and when administered sublingually the weights are within the ratio of 1:2 to 2:1.
REFERENCES:
Chem. Abst. 94-150268y (1984).
Chemical Abstracts 90, 145726j.
Manara et al., Dev. Neurosci, (Amsterdam) 1978, 4 (Charact. Funct. Opioids) 225-6.
Dettmar et al., Biochem. Soc. Trans. 1978, 6(5), 1004-6 (=Chem. Abs. 90, 197597n (1979).
Ramabadran et al., Endog. Exog. Opiate Agonists Antagonists, Proc. Int. Narc. Res. Club. Conf. 1979 (Pub 1980) 471-4 (-Chem. Abs. 94, 15027u (1981)).
Rance et al., Endog. Exog. Opiate Angonists Antagonists, Proc. Int. Narc. Res. Club. Conf. 1979 (Pub 1980) 387-90 (-Chem. Abs., 94, 150268y (1981)).
Lewis John W.
Lloyd-Jones John G.
Friedman Stanley J.
Reckitt & Colman Products Limited
LandOfFree
Analgesic compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Analgesic compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Analgesic compositions will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1439126